France To Replace AstraZeneca Booster With mRNA Jab In Under-55s

The French authorities believe that the “heterologous prime-boost” approach is justified in the case of people aged under 55 years who are due to receive their second dose of the AZ COVID-19 vaccine.

Covid south africa variant, covid-19 virus with african green flag
The South African coronavirus variant is one of those at large in France • Source: Alamy

The French government says that people under the age of 55 years who have had their first injection with the Oxford/AstraZeneca PLC COVID-19 vaccine should be given an mRNA vaccine as a booster in view of the incidence of unusual blood clots seen in younger populations who were given the AstraZeneca jab.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from France

More from Europe